Finance

Beta
Lists
VTVT:NASDAQ
vTv Therapeutics Inc
$32.29
-1.22%
(-0.40) 1D
Jul 16, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VTVT...
Open
$34.02
High
$34.02
Low
$32.29
Mkt. cap
127.19M
Avg. vol.
54.39K
Volume
114.25K
52-wk high
$44.00
52-wk low
$14.00
EPS
-$0.92
Beta
0.27
Shares outstanding
3.94M
No. of employees
26
Open
$34.02
High
$34.02
Low
$32.29
Mkt. cap
127.19M
Avg. vol.
54.39K
Volume
114.25K
52-wk high
$44.00
52-wk low
$14.00
EPS
-$0.92
Beta
0.27
Shares outstanding
3.94M
No. of employees
26
News stories
From sources across the web
About vTv Therapeutics Inc
CEO-
Employees26
Founded2015
HeadquartersHigh Point, North Carolina, United States
SectorBiotechnology
Websitevtvtherapeutics.com
Analyst ratings
Based on 6 analysts giving stock ratings to VTVT in the past 3 months
Strong buy
Buy
6
Hold
0
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for VTVT in the last 3 months.
Highest
Current $32.29
$67.00 (+107.49%)
Average
$58.17 (+80.15%)
Lowest
$45.00 (+39.36%)
Analyst
Recommendation
Action
Price target
Projected
Date
Kambiz Yazdi
BTIG
Buy
Reiterated
$57.00
+76.5%
07/16/2026
Michael King
Rodman & Renshaw
Buy
Initiated
$67.00
+107.5%
06/30/2026
Emily Bodnar
H.C. Wainwright
Buy
Maintained
$45.00
+39.4%
05/26/2026
Ritu Baral
TD Cowen
Buy
Maintained
$67.00
+107.5%
05/14/2026
James Molloy
Alliance Global Partners
Buy
Reiterated
$55.00
+70.3%
05/14/2026
Adam Walsh
Roth MKM
Buy
Reiterated
$58.00
+79.6%
05/13/2026
Michael DiFiore
Evercore ISI
Buy
Initiated
$44.00
+36.3%
03/12/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
36.84M
Cost of goods sold
4.10M
7.02M
3.91M
8.98M
Cost of revenue
4.10M
7.02M
3.91M
8.98M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.62M
3.68M
3.98M
4.60M
Operating expense
3.62M
3.68M
3.98M
4.60M
Total operating expenses
7.72M
10.70M
7.88M
13.58M
Operating income
-7.72M
-10.70M
-7.88M
23.26M
Other non operating income
66.00K
-40.00K
-117.00K
33.00K
EBT including unusual items
-7.38M
-10.34M
-7.14M
24.13M
EBT excluding unusual items
-7.38M
-10.34M
-7.14M
24.13M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-6.05M
-8.70M
-7.14M
24.13M
Net profit margin
-
-
-
65.51%
Earnings per share
-0.92
-1.08
-0.58
1.65
Interest and investment income
275.00K
399.00K
865.00K
838.00K
Interest expense
-
-5.00K
-1.00K
-
Net interest expenses
275.00K
394.00K
864.00K
838.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-7.72M
-10.70M
-7.88M
23.26M
Gain or loss from assets sale
-
-
6.00K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer